2011 Scrip 100: Surfing the social media wave
This article was originally published in Scrip
Pharma should be chomping at the bit to incorporate social media channels into its marketing plans, but hesitance remains. What is holding industry back, and how can it seize Web 2.0 opportunities in the future, asks Rebecca Debens.
You may also be interested in...
Collaborations with big pharma, healthy venture investments and a robust pipeline make Shanghai-based Hutchison MediPharma a blueprint for Asian bioventures. CEO Dr Samantha Du discusses with Rebecca Debens deals, drug development and doing business in China. This article is part of the 2011 Scrip Asia 100.